News in the Life Sciences Industry

DUBLIN, Oct. 14, 2019 /PRNewswire/ -- The Read more ››

CARLSBAD, Calif., Oct. 14, 2019 /PRNewswire/ -- Biologica Technologies, developers and marketers of ProteiOS®, announced today that they have been recognized as one of the Top 10 MedTech Startups in 2019 by MedTech Outlook Magazine.

MARIETTA, Ga., Oct. 14, 2019 /PRNewswire/ -- Dr. Noel Holtz, MD, is being recognized by Continental Who's Who as a Leading Medical Professional in the field of Medicine as the Medical Director at Wellstar Health System.

With its global medical IoT infrastructure, Medisanté radically simplifies PGHD integration into clinical systems and enables healthcare providers to scale their RPM initiatives

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD) ("Aethlon" or the "Company"), a therapeutic medical device and technology company focused on unmet needs in global health, announced today that at the annual meeting of stockholders of the Company, held October 14,... Read more ››

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Irritable Bowel Syndrome (IBS) Therapeutics market worldwide is projected to grow by US$4 Billion, driven by a compounded growth of 16.2%. BS-D Drug, one of the segments analyzed and sized in this study, displays the potential to grow at over 15.7%. The... Read more ››

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report third quarter financial results after the Nasdaq market closes on Monday, November 4, 2019. Neurocrine will then host a conference call and webcast to discuss its financial... Read more ››

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Kidney Cancer Drugs market worldwide is projected to grow by US$2 Billion, driven by a compounded growth of 5.1%. Targeted Therapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.4%. The shifting dynamics... Read more ››

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced... Read more ››

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2019 earnings results... Read more ››

DUBLIN, Oct. 14, 2019 /PRNewswire/ -- The Read more ››

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, announced today that it will release top-line data from its Phase 2 study of REL-1017 in patients... Read more ››

NEW YORK, Oct. 14, 2019 /PRNewswire/ -- Nucleic Acid Testing market worldwide is projected to grow by US$1.5 Billion, driven by a compounded growth of 7.2%. Nucleic Acid Test Kits, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.3%. The shifting... Read more ››

DUBLIN, Oct. 14, 2019 /PRNewswire/ -- The Read more ››

MILL VALLEY, Calif. and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Collaborative Medicinal Development, LLC) ("CMD"), a clinical stage biopharmaceutical company with a portfolio of candidates for treatment of neurological and neuropsychiatric diseases, announced today that it enrolled... Read more ››

DUBLIN, Oct. 14, 2019 /PRNewswire/ -- The Read more ››